Apimeds Pharmaceuticals US Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Apimeds Pharmaceuticals US Inc.
Apimeds Pharmaceuticals Us Inc is a clinical-stage company. It is engaged in a pharmaceutical business that provides the biological drug Apitox to clients in the biological drug commercial transaction area. It are a clinical stage biopharmaceutical company in the process of developing Apitox, an intradermally administered bee venom-based toxin. Company focus is on developing therapies that address inflammation and pain management symptoms associated with knee OA and, to a lesser extent, MS. Apitox is currently marketed and sold by Apimeds Inc. in South Korea as Apitoxin for the treatment of OA.
/ 
Frequently asked questions
To buy Apimeds Pharmaceuticals US Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Apimeds Pharmaceuticals US Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Apimeds Pharmaceuticals US Inc. is APUS:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Apimeds Pharmaceuticals US Inc. has its primary listing on NYSE American. You can trade Apimeds Pharmaceuticals US Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Apimeds Pharmaceuticals US Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Apimeds Pharmaceuticals US Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Apimeds Pharmaceuticals US Inc..